drugset / Trial / NCT01230970

Exploratory Study to Assess the Short Term Intratumoural and Peripheral Effects of BN83495 in Postmenopausal Women With Newly Diagnosed Breast Cancer

NCT01230970

Phase 2 Terminated 2 enrolled Ipsen
Non-randomizedSingle-groupOpen-labelBasic science

Summary

This trial will assess the intratumoural pharmacological activity of BN83495 by changes in intratumoural levels of sex hormones and associated inhibition of steroid sulphatase (STS) activity.

Timeline

Start
2011-05
Primary completion
2011-05
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Irosustat Small molecule 40 mg Oral

Indications